Literature DB >> 11454858

An extra nucleotide in the consensus catalytic core of a viroid hammerhead ribozyme: implications for the design of more efficient ribozymes.

M De la Peña1, R Flores.   

Abstract

Hammerhead ribozymes catalyze self-cleavage of oligomeric RNAs generated in replication of certain viroid and viroid-like RNAs. Previous studies have defined a catalytic core conserved in most natural hammerheads, but it is still unknown why some present deviations from the consensus. We have addressed this issue in chrysanthemum chlorotic mottle viroid (CChMVd), whose (+) hammerhead has an extra A (A10) between the conserved A9 and the quasi-conserved G10.1. Effects of insertions at this position on hammerhead kinetics have not hitherto been examined. A10 caused a moderate decrease of the trans-cleaving rate constant with respect to the CChMVd (+) hammerhead without this residue, whereas A10-->C and A10-->G substitutions had major detrimental effects, likely because they favor catalytically inactive foldings. By contrast, A10-->U substitution induced a 3-4-fold increase of the rate constant, providing an explanation for the extra U10 present in two natural hammerheads. Because A10 also occupies a singular and indispensable position in the global CChMVd conformation, as revealed by bioassays, these results show that some hammerheads deviate from the consensus due to the involvement of certain residues in critical function(s) other than self-cleavage. Incorporation of the extra U10 into a model hammerhead also caused a similar increase in the rate constant, providing data for a deeper understanding of the hammerhead structural requirements and for designing more efficient ribozymes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454858     DOI: 10.1074/jbc.M103867200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Peripheral regions of natural hammerhead ribozymes greatly increase their self-cleavage activity.

Authors:  Marcos De la Peña; Selma Gago; Ricardo Flores
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

Review 2.  The ubiquitous hammerhead ribozyme.

Authors:  Christian Hammann; Andrej Luptak; Jonathan Perreault; Marcos de la Peña
Journal:  RNA       Date:  2012-03-27       Impact factor: 4.942

3.  Ubiquitous presence of the hammerhead ribozyme motif along the tree of life.

Authors:  Marcos de la Peña; Inmaculada García-Robles
Journal:  RNA       Date:  2010-08-12       Impact factor: 4.942

4.  Enhanced product stability in the hammerhead ribozyme.

Authors:  Irina Shepotinovskaya; Olke C Uhlenbeck
Journal:  Biochemistry       Date:  2010-06-01       Impact factor: 3.162

Review 5.  Hammerhead redux: does the new structure fit the old biochemical data?

Authors:  Jennifer A Nelson; Olke C Uhlenbeck
Journal:  RNA       Date:  2008-02-20       Impact factor: 4.942

6.  Catalytic diversity of extended hammerhead ribozymes.

Authors:  Irina V Shepotinovskaya; Olke C Uhlenbeck
Journal:  Biochemistry       Date:  2008-06-11       Impact factor: 3.162

Review 7.  The hammerhead ribozyme: structure, catalysis, and gene regulation.

Authors:  William G Scott; Lucas H Horan; Monika Martick
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

8.  Structure-based search reveals hammerhead ribozymes in the human microbiome.

Authors:  Randi M Jimenez; Eric Delwart; Andrej Lupták
Journal:  J Biol Chem       Date:  2011-01-21       Impact factor: 5.157

9.  Trans-cleaving hammerhead ribozymes with tertiary stabilizing motifs: in vitro and in vivo activity against a structured viroid RNA.

Authors:  Alberto Carbonell; Ricardo Flores; Selma Gago
Journal:  Nucleic Acids Res       Date:  2010-11-21       Impact factor: 16.971

10.  Viroids: from genotype to phenotype just relying on RNA sequence and structural motifs.

Authors:  Ricardo Flores; Pedro Serra; Sofía Minoia; Francesco Di Serio; Beatriz Navarro
Journal:  Front Microbiol       Date:  2012-06-18       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.